Sustained estrogen exposure drove an ESR1-PRL autocrine loop, mirroring clinical observations of hormone receptor upregulation in aggressive PitNETs.66,67 These parallels suggest that the model may help explore how tumor-immune interactions contribute to disease and could provide a platform for testing targeted therapies aimed at restoring immune balance. This evidence concerns the gene PRL and neoplasm.